ClinicalTrials.Veeva

Menu

Pharmaceutical Consultation at Hospital Discharge and Adherence to Anti-infective Treatment (CPS-INFECTIO)

C

Centre Hospitalier Universitaire de Nīmes

Status

Completed

Conditions

Infection

Treatments

Other: Pharma consult
Other: Routine care

Study type

Interventional

Funder types

Other

Identifiers

NCT02126930
LOCAL/2014/HF-01
2014-A00944-43 (Other Identifier)
LOCAL/2014/AS-01 (Other Identifier)
2014-A00335-42 (Other Identifier)

Details and patient eligibility

About

The main objective of this study is to evaluate the impact of a pharmaceutical consultation at the time of hospital discharge on the adherence of patients ; non-adherence is determined by the following criteria:

As concerns prescribed anti-infectious treatments, at least one of the following 4 criteria is true:

  1. . the patient did not go and get his/her treatment at the pharmacy;
  2. . the number of treatment units dispensed by the pharmacy is < the number of treatment units prescribed;
  3. . the patient stopped taking a treatment before the recommended time, or continued taking a treatment after the recommended time;
  4. . the number of treatment units taken by the patient (self-declaration) is < or > to the number of units prescribed.

Full description

The secondary objectives of this study are :

A- To assess the percentage of patients who obtained their anti- infective pharmaceuticals

B- To evaluate the ratio of the number of units of anti- infective drugs dispensed by the pharmacy over the number of units of anti- infective drugs prescribed

C- To determine the ratio of the number of premature discontinuations of anti -infective treatments over the number of lines of anti -infective treatments prescribed

D- Evaluate the ratio of the number of units actually taken by the patient (based on a self-declaration) over the number of units of anti- infective drugs prescribed

E- To measure the comprehension concerning anti- infective treatments after returning home (based on a quiz)

F- To determine the risk factors for non- adherence to anti- infective therapy based on the characteristics of the study population

G- Assess patient satisfaction concerning a pharmaceutical consultation at hospital discharge (questionnaire)

H- Assess the impact of a pharmaceutical consultation on primary non-adherence (criteria 1 and 2) and secondary non- adherence (criteria 3 and 4)

Enrollment

174 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient is hospitalized in the Infectious and Tropical Diseases department of the Nîmes University Hospital, and is scheduled for hospital discharge with one or more pharmaceutical prescriptions for anti-infectious treatments

Exclusion criteria

  • The patient is participating in another study
  • The patient is in an exclusion period determined by a previous study
  • The patient is under judicial protection
  • The patient refuses to sign the consent
  • It is impossible to correctly inform the patient
  • The patient resides in a care establishment, or has home medical/nursing service
  • The patient is suffering from chronic infection (>4 weeks of treatment required)
  • The patient is suffering from handicapping deafness, dementia, or does not have a telephone
  • Intravenous, intramuscular or subcutaneous anti-infectious treatments are prescribed
  • Prescription of antiretroviral treatments

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

174 participants in 2 patient groups

Routine care
Active Comparator group
Description:
The patients in this receive routine care. Intervention: Routine care
Treatment:
Other: Routine care
Pharma consult
Experimental group
Description:
The patients in this arm will have a pharmaceutical consult upon hospital discharge. Intervention: Pharma consult
Treatment:
Other: Pharma consult

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems